Tag - vaccinations

 
Menu
Search
 
November 22, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

VACCINATIONS

The H5N1 bird flu virus, which has been found in cattle, is a pathogen that has loomed large in the minds of infectious disease experts for its potential to cause a deadly human pandemic.
COMMENTARY / World
May 9, 2024
The bird flu outbreak brings more questions than answers
This is a pathogen that has loomed large in the minds of infectious disease experts for its potential to cause a deadly human pandemic.
A new study has found that women with long COVID had significantly lower levels of testosterone compared to those who had recovered from their infection.
COMMENTARY / World
Apr 17, 2024
Sex differences could be key to the successful treatment of long COVID
New research links testosterone levels to the severity of long COVID in women.
Measles has a typical incubation period of 10 to 12 days, though this can extend to as long as 21 days. Early symptoms include a fever, cough and a runny nose.
JAPAN / Science & Health
Mar 22, 2024
Japan urges priority for children as demand for measles shots spikes
Recent outbreaks in the country have led to a surge in interest in the vaccine among unvaccinated adults who haven't been infected with the disease.
Measles is highly contagious and is characterized by symptoms such as a mild to moderate fever and a cough, followed by high fever and rash. The virus spreads through airborne transmission.
JAPAN / Science & Health
Mar 12, 2024
Health ministry urges caution after measles outbreak
Eight cases have been confirmed among passengers of a flight from the United Arab Emirates that landed at Kansai International Airport in late February.
Takeda Pharmaceutical is in talks to make its dengue vaccine available in India.
BUSINESS / Companies
Feb 28, 2024
Takeda in regulatory talks to launch dengue vaccine in India
Takeda's dengue vaccine is currently available for children and adults in countries like Indonesia, Thailand, Argentina and Brazil.
Take any scientific issue that involves political choices, from public health to climate change, all sides claim to be basing their concerns on science.
COMMENTARY / World
Jan 2, 2024
Let’s stop insulting each other as ‘anti-science’
Take any scientific issue that involves political choices, from public health to climate change, all sides claim to be basing their concerns in science.
Demonstrators rally against COVID-19 vaccine mandates in Buffalo, New York, in February 2022.
COMMENTARY / World
Dec 26, 2023
It’s past time scientists admitted their COVID-19 mistakes
In 2019, 13% of Americans were distrustful enough to say they weren’t confident in scientists to act in the public’s best interest. Now it is 27%.
Alex Zhavoronkov, founder and chairman of Insilico Medicine, poses at his research facility in Suzhou, China, on Oct. 31.
WORLD / Science & Health
Nov 14, 2023
Race for first drug discovered by AI nears key milestone
Insilico Medicine's AI-developed drug for idiopathic pulmonary fibrosis is in midstage trials in the U.S. and China.
A health care worker administers the COVID-19 vaccine to a child in Rio de Janeiro in January 2022.
COMMENTARY / World
Oct 30, 2023
How we got COVID’s risk right but the response wrong
It was not the initial consensus on the fatality rate that drove the response but rather the way the risks of COVID-19 were balanced with the costs.
Troy Sutton, a virologist at Pennsylvania State University, on July 25, 2023. Sutton says that health officials referred to the public controversy over the lab leak theory in advising him to pursue different experiments.
WORLD / Science & Health
Oct 18, 2023
Lab leak fight casts chill over virology research
While some believe practices such as gain-of-function research could fend off the next pandemic, others worry that they are more likely to start one.
When COVID-19 first emerged, companies across the health care industry raced to reconfigure themselves. That transformation is now unraveling.
BUSINESS / Companies
Oct 18, 2023
Life after COVID turns rocky for reshaped health care businesses
When the coronavirus first emerged, companies across the health care industry raced to reconfigure themselves. That transformation is now unraveling.
Employees monitor the production of Covishield, the local name for the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, at the Serum Institute of India in Pune, Maharashtra, India.
BUSINESS / Companies
Oct 5, 2023
Top vaccine maker seeks growth by selling shots to globetrotters
Serum Institute of India plans to start production of yellow fever and dengue shots for travelers to countries where those diseases are endemic.
A new study defines some critical differences in certain biomarkers of people with long COVID.
COMMENTARY / World
Oct 4, 2023
Long COVID is real. Now the evidence is piling up.
In what the researchers believe is a first, they did a detailed study of the differences between people with long COVID and those who are healthy.
A nurse prepares a malaria vaccine before administering it to an infant in Kisumu, Kenya, in July 2022.
WORLD / Science & Health
Oct 3, 2023
WHO recommends malaria vaccine that will be rolled out next year
R21/Matrix-M, developed by Britain's University of Oxford, will become available by mid-2024
Katalin Kariko (right) and Drew Weissman, the winners of the 2023 Nobel Prize in physiology or medicine for their discoveries enabling the development of mRNA COVID-19 vaccines
COMMENTARY / World
Oct 3, 2023
Nobel for mRNA vaccines shows the power of perseverance
Decades of work by Nobel Prize winners Kariko and Weissman made the rapid development of COVID-19 mRNA vaccines possible.
A screen at the Karolinska Institute shows this year's laureates Katalin Kariko of Hungary (left) and Drew Weissman of the U.S. during the announcement of the winners of the Nobel Prize in physiology or medicine.
WORLD / Science & Health
Oct 2, 2023
Pair win medicine Nobel for work related to COVID-19 vaccines
Their findings "fundamentally changed our understanding of how mRNA interacts with our immune system," the Nobel committee said.
A vial of the Moderna COVID-19 booster vaccine targeting BA.4 and BA.5 omicron subvariants. Japan will roll out an updated version targeting the XBB variant on Wednesday.
JAPAN / Explainer
Sep 19, 2023
Japan to begin COVID vaccine drive targeting XBB subvariant
The free shots will be offered until March next year to prepare residents for an expected uptick in infections during the winter.
A man receives a COVID-19 vaccination at Aoyama University in Tokyo in August 2021.
JAPAN / Science & Health
Sep 9, 2023
Japan to end free COVID-19 vaccinations in March
From fiscal 2024, the country will provide a COVID-19 shot once a year between to people aged 65 or over who are at high risk of severe symptoms.
Preliminary data suggests that updated COVID-19 boosters, which are matched to a previous variant known as XBB, could still offer protection against the new edition.
COMMENTARY / World
Sep 7, 2023
New Pirola COVID-19 variant shows value of booster shots
Data suggests the updated COVID-19 boosters, which are matched to the XBB variant, could still offer decent protection against the new edition.
One big challenge public health officials now face is how to restore trust so that people listen to future guidance on everything from flu shots to childhood vaccines.
COMMENTARY / World
Aug 27, 2023
Not all COVID-19 ‘misinformation’ is equal — nor misinformation
Public health scientists have to figure out how to get back to the kind of nuanced, thoughtful discussions that were the pre-pandemic norm.
Two of America’s biggest debt holders are dumping Treasurys
The U.S. Treasury building in Washington. Investors in Japan and China sold a pile of U.S. debt in the last quarter, just before the U.S. presidential election.
Ishiba aggravates his own political failures with diplomatic faux pas
Prime Minster Shigeru Ishiba is greeted at the APEC summit in Lima by Canadian Prime Minister Justin Trudeau on Friday. The Japanese leader was criticized for remaining seated while meeting several world leaders at the event.
Japan's 3.31 million visitors in October set monthly record
Kiyomizu Temple in Kyoto in December 2023. Famous autumn leaf colors contributed to increased tourism demand last month from many markets across Asia, Europe and North America, the Japan National Tourism Organization has said.
Japan ranks last in romance satisfaction for second straight year
In a survey of 31 countries, Japan ranked last in terms of those who felt loved, with just 51% of respondents saying so.
Ruling coalition and DPP strike last-minute deal over economic policy
DPP policy chief Makoto Mahaguchi speaks at the party's policy gathering in Tokyo on Wednesday.
Japan, U.K. and Italy discuss inviting more countries to joint fighter project
A new concept model of a next-generation fighter jet to be jointly developed by Japan, Britain and Italy is on display in Farnborough, Hampshire, in July.
Haruki Murakami's 'The City and Its Uncertain Walls' gives deep deja vu
For “The City and Its Uncertain Walls,” translated into English by Philip Gabriel, Haruki Murakami confronts the ghosts who won't leave him alone.
Japanese expats in Asia find community through rugby
The Taiwan Fivewoods celebrate their victory at the 2023 Asian Japanese Rugby Cup in December of last year.
In Fukushima, a weekend of prose, poetry and translation
Aomori-based writer JJ Carter presented on tabletop gaming as creative inspiration for building characters and narratives.
For Dr. Nakamats, aging is just experience in action
Though he didn't win the recent gubernatorial election in Tokyo, the 96-year-old Dr. Nakamats' run was seen as inspirational in Japan's aging society.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

mission sustainability vol.12 : Kose Corp.Kose takes pride in creating beauty in the world
mission sustainability vol.12 : Kose Corp.Kose takes pride in creating beauty in the world

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER